Published in Environ Health Perspect on February 26, 2009
Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: evidence for endocrine disruption. Environ Health Perspect (2010) 1.75
Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells. Environ Health Perspect (2012) 1.70
Genome-wide gene amplification during differentiation of neural progenitor cells in vitro. PLoS One (2012) 1.14
Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery. Arch Toxicol (2014) 0.99
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX (2014) 0.94
Human cell-based micro electrode array platform for studying neurotoxicity. Front Neuroeng (2010) 0.89
Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres. PLoS One (2014) 0.88
International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Arch Toxicol (2015) 0.87
Toward a 3D model of human brain development for studying gene/environment interactions. Stem Cell Res Ther (2013) 0.86
Gold- and silver nanoparticles affect the growth characteristics of human embryonic neural precursor cells. PLoS One (2013) 0.86
Biological and medical applications of a brain-on-a-chip. Exp Biol Med (Maywood) (2014) 0.84
PPTOX III: environmental stressors in the developmental origins of disease--evidence and mechanisms. Toxicol Sci (2012) 0.84
The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology (2012) 0.82
Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environ Health Perspect (2010) 0.81
Imaging of human differentiated 3D neural aggregates using light sheet fluorescence microscopy. Front Cell Neurosci (2014) 0.79
Optimizing culture medium composition to improve oligodendrocyte progenitor cell yields in vitro from subventricular zone-derived neural progenitor cell neurospheres. PLoS One (2015) 0.79
A human pluripotent stem cell platform for assessing developmental neural toxicity screening. Stem Cell Res Ther (2013) 0.78
Neural Differentiation of Human Pluripotent Stem Cells for Nontherapeutic Applications: Toxicology, Pharmacology, and In Vitro Disease Modeling. Stem Cells Int (2015) 0.77
Low level methylmercury enhances CNTF-evoked STAT3 signaling and glial differentiation in cultured cortical progenitor cells. Neurotoxicology (2013) 0.77
Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues. Front Physiol (2012) 0.76
Growing knowledge: using stem cells to study developmental neurotoxicity. Environ Health Perspect (2010) 0.76
Functional metabolic interactions of human neuron-astrocyte 3D in vitro networks. Sci Rep (2016) 0.75
BDE-99 impairs differentiation of human and mouse NPCs into the oligodendroglial lineage by species-specific modes of action. Sci Rep (2017) 0.75
Sensitivity of neural stem cell survival, differentiation and neurite outgrowth within 3D hydrogels to environmental heavy metals. Toxicol Lett (2015) 0.75
Effect of Lycium bararum polysaccharides on methylmercury-induced abnormal differentiation of hippocampal stem cells. Exp Ther Med (2016) 0.75
Developmental neurotoxic effects of Malathion on 3D neurosphere system. Appl Transl Genom (2015) 0.75
Gestational Age and Sex Influence the Susceptibility of Human Neural Progenitor Cells to Low Levels of MeHg. Neurotox Res (2017) 0.75
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect (2000) 7.58
Toxicology. Transforming environmental health protection. Science (2008) 7.50
Developmental neurotoxicity of industrial chemicals. Lancet (2006) 7.37
Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev (2001) 5.50
Neural stem cells and neurospheres--re-evaluating the relationship. Nat Methods (2005) 3.92
The three modern faces of mercury. Environ Health Perspect (2002) 3.33
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol (1999) 2.78
New directions in neuronal migration. Science (2002) 2.36
Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J (2009) 2.35
Regulation of human neural precursor cells by laminin and integrins. J Neurosci Res (2006) 2.30
In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun (2001) 2.17
Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol (2002) 2.04
Beta1 integrins activate a MAPK signalling pathway in neural stem cells that contributes to their maintenance. Development (2004) 2.04
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol (2003) 1.99
Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release. Cell Death Differ (2000) 1.92
Chemicals in the environment and developmental toxicity to children: a public health and policy perspective. Environ Health Perspect (2000) 1.77
The pharmacology of mercury compounds. Annu Rev Pharmacol (1972) 1.58
Developing brain as a target of toxicity. Environ Health Perspect (1995) 1.56
Neurotoxicity and molecular effects of methylmercury. Brain Res Bull (2001) 1.53
Toxic threats to neurologic development of children. Environ Health Perspect (2001) 1.39
Mercury: major issues in environmental health. Environ Health Perspect (1993) 1.33
Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect (2007) 1.26
Neurotoxicity of organomercurial compounds. Neurotox Res (2003) 1.10
High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. J Neurochem (2006) 1.10
The effects of methylmercury on the developing brain. Prog Neurobiol (1989) 1.07
Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors. Environ Health Perspect (2005) 1.04
Free radicals and brain damage in the newborn. Biol Neonate (2001) 1.03
Oxidative mechanisms underlying methyl mercury neurotoxicity. Int J Dev Neurosci (1991) 0.99
In vitro and other alternative approaches to developmental neurotoxicity testing (DNT). Environ Toxicol Pharmacol (2005) 0.98
Meeting report: alternatives for developmental neurotoxicity testing. Environ Health Perspect (2007) 0.97
Thalidomide resistance is based on the capacity of the glutathione-dependent antioxidant defense. Mol Pharm (2009) 0.97
Methylmercury poisoning induces oxidative stress in the mouse brain. Exp Mol Pathol (1994) 0.88
Effect of methylmercury on midbrain cell proliferation during organogenesis: potential cross-species differences and implications for risk assessment. Toxicol Sci (2003) 0.88
ERK-dependent and -independent pathways trigger human neural progenitor cell migration. Toxicol Appl Pharmacol (2007) 0.87
Effect of oxidative preconditioning on neural progenitor cells. Brain Res (2008) 0.84
The need for developmental neurotoxicity studies in risk assessment for developmental toxicity. Reprod Toxicol (2006) 0.84
Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon. Brain Res (1996) 0.83
Inorganic mercury changes the fate of murine CNS stem cells. FASEB J (2003) 0.81
Apoptotic morphology does not always require caspase activity in rat cerebellar granule neurons. Neurotox Res (2001) 0.79
Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci U S A (2007) 2.08
Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: evidence for endocrine disruption. Environ Health Perspect (2010) 1.75
Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci U S A (2008) 1.43
Analysis of the transcriptional regulation and molecular function of the aryl hydrocarbon receptor repressor in human cell lines. Drug Metab Dispos (2007) 1.16
Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem Pharmacol (2008) 1.16
Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A (2008) 1.14
The aryl hydrocarbon receptor and light. Biol Chem (2006) 1.10
Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol Teratol (2009) 1.09
The compatible solute ectoine protects against nanoparticle-induced neutrophilic lung inflammation. Am J Respir Crit Care Med (2009) 1.08
Ultrafine carbon particles induce apoptosis and proliferation in rat lung epithelial cells via specific signaling pathways both using EGF-R. Am J Physiol Lung Cell Mol Physiol (2006) 1.05
Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors. Environ Health Perspect (2005) 1.04
Detection of prion particles in samples of BSE and scrapie by fluorescence correlation spectroscopy without proteinase K digestion. Biol Chem (2006) 1.00
Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr Cancer (2004) 1.00
The AhR-Nrf2 pathway in keratinocytes: on the road to chemoprevention? J Invest Dermatol (2012) 0.98
The arylhydrocarbon receptor repressor (AhRR): structure, expression, and function. Biol Chem (2006) 0.98
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX (2014) 0.94
Counting of single prion particles bound to a capture-antibody surface (surface-FIDA). Vet Microbiol (2007) 0.93
Localization of proteasomes and proteasomal proteolysis in the mammalian interphase cell nucleus by systematic application of immunocytochemistry. Histochem Cell Biol (2007) 0.93
Estradiol protects dermal hyaluronan/versican matrix during photoaging by release of epidermal growth factor from keratinocytes. J Biol Chem (2012) 0.93
Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. Pharmacogenetics (2003) 0.93
A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. Eur J Hum Genet (2002) 0.93
Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. J Invest Dermatol (2012) 0.92
Distinct spectrum of mutations induced by crocidolite asbestos: clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. Cancer Res (2002) 0.91
Tissue distribution and function of the Aryl hydrocarbon receptor repressor (AhRR) in C57BL/6 and Aryl hydrocarbon receptor deficient mice. Arch Toxicol (2006) 0.91
Carbon nanoparticle-induced lung epithelial cell proliferation is mediated by receptor-dependent Akt activation. Am J Physiol Lung Cell Mol Physiol (2007) 0.90
Impact of the arylhydrocarbon receptor on eugenol- and isoeugenol-induced cell cycle arrest in human immortalized keratinocytes (HaCaT). Biol Chem (2006) 0.90
A prevalent POLG CAG microsatellite length allele in humans and African great apes. Mamm Genome (2004) 0.89
Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol (2012) 0.88
Reactive oxygen species as mediators of membrane-dependent signaling induced by ultrafine particles. Free Radic Biol Med (2010) 0.88
Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX (2012) 0.88
ERK-dependent and -independent pathways trigger human neural progenitor cell migration. Toxicol Appl Pharmacol (2007) 0.87
International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Arch Toxicol (2015) 0.87
beta1-integrin mediates asbestos-induced phosphorylation of AKT and ERK1/2 in a rat pleural mesothelial cell line. Oncogene (2003) 0.85
Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes. Exp Dermatol (2012) 0.84
The Aryl hydrocarbon receptor is involved in UVR-induced immunosuppression. J Invest Dermatol (2013) 0.83
Regulation of dioxin receptor function by different beta-carboline alkaloids. Arch Toxicol (2010) 0.83
Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environ Health Perspect (2010) 0.81
The polysaccharide scaffold of PrP 27-30 is a common compound of natural prions and consists of alpha-linked polyglucose. Biol Chem (2005) 0.81
Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study. J Toxicol Environ Health A (2008) 0.81
Role of the aryl hydrocarbon receptor in tobacco smoke extract-induced matrix metalloproteinase-1 expression. Exp Dermatol (2013) 0.81
Nitric oxide stimulates human neural progenitor cell migration via cGMP-mediated signal transduction. Cell Mol Life Sci (2010) 0.81
Khellin and visnagin differentially modulate AHR signaling and downstream CYP1A activity in human liver cells. PLoS One (2013) 0.80
Putative adverse outcome pathways relevant to neurotoxicity. Crit Rev Toxicol (2015) 0.80
Association between head and neck cancer and microsomal epoxide hydrolase genotypes. Arch Toxicol (2002) 0.80
In vitro neurotoxicity data in human risk assessment of polybrominated diphenyl ethers (PBDEs): overview and perspectives. Toxicol In Vitro (2011) 0.79
Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling. PLoS One (2012) 0.79
The interleukin-6-type cytokine oncostatin M induces aryl hydrocarbon receptor expression in a STAT3-dependent manner in human HepG2 hepatoma cells. FEBS J (2013) 0.79
Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2). Arch Toxicol (2014) 0.78
Concepts in molecular dermatotoxicology. Exp Dermatol (2006) 0.78
Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. J Invest Dermatol (2003) 0.77
Neurospheres as a model for developmental neurotoxicity testing. Methods Mol Biol (2011) 0.77
Comparative human and rat "neurosphere assay" for developmental neurotoxicity testing. Curr Protoc Toxicol (2014) 0.77
Epigallocatechin-3-gallate does not affect the activity of enzymes involved in metabolic activation and cellular excretion of benzo[a]pyrene in human colon carcinoma cells. Toxicol Lett (2011) 0.77
BDE-47 and 6-OH-BDE-47 modulate calcium homeostasis in primary fetal human neural progenitor cells via ryanodine receptor-independent mechanisms. Arch Toxicol (2014) 0.77
Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations. Toxicol Sci (2013) 0.77
Induction of 8-hydroxydeoxyguanosine by man made vitreous fibres and crocidolite asbestos administered intraperitoneally in rats. Mutat Res (2004) 0.76
In vitro conversion and seeded fibrillization of posttranslationally modified prion protein. Biol Chem (2011) 0.76
Luteolin enhances the bioavailability of benzo(a)pyrene in human colon carcinoma cells. Arch Biochem Biophys (2010) 0.75
International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes. ALTEX (2014) 0.75
Effects of the genotoxic compounds, benzo[a]pyrene and cyclophosphamide on phase 1 and 2 activities in EpiDerm™ models. Xenobiotica (2011) 0.75